Cargando…

Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population

INTRODUCTION: The efficacy of cyclosporine A (CsA) in the treatment of idiopathic membranous nephropathy (IMN) is unclear. This meta-analysis was conducted to assess the efficacy and the safety of CsA in the treatment of IMN in Asians. METHODS: We searched the Pubmed, China Biomedical Database, CNKI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shujun, Li, Hong-Yan, Zhou, Tianbiao, Lin, Wenshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628962/ https://www.ncbi.nlm.nih.gov/pubmed/31371924 http://dx.doi.org/10.2147/DDDT.S204974

Ejemplares similares

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2019)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis
por: Zhong, Hongzhen, et al.
Publicado: (2020)

Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
por: Yu, Xiaojuan, et al.
Publicado: (2017)

Relationship between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation recipients
por: Li, Hong-Yan, et al.
Publicado: (2019)

Stepwise Treatment Using Corticosteroids Alone and in Combination with Cyclosporine in Korean Patients with Idiopathic Membranous Nephropathy
por: Shin, Dong Ho, et al.
Publicado: (2013)

The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Association of hypoxia-inducible factor-1α (HIF1α) 1790G/A gene polymorphism with renal cell carcinoma and prostate cancer susceptibility: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants
por: Lin, Shujun, et al.
Publicado: (2020)

Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Lu, Huijuan, et al.
Publicado: (2022)

Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal
por: Rojas-Rivera, Jorge Enrique, et al.
Publicado: (2019)

All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats
por: Zhong, Zhiqing, et al.
Publicado: (2021)

Clinical efficacy and safety of different tacrolimus concentrations for the treatment of patients with idiopathic membranous nephropathy
por: Wang, Qi, et al.
Publicado: (2021)

Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2021)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013)

Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
por: Schultz, Clyde
Publicado: (2014)

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
por: Liang, Qian, et al.
Publicado: (2017)

Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019)

Idiopathic Membranous Nephropathy and Treatment Related Complications
por: Uncanin, Snezana, et al.
Publicado: (2020)

Association of Nuclear Receptor Coactivators with Hypoxia-Inducible Factor-1α in the Serum of Patients with Chronic Kidney Disease
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience
por: Chen, Ping, et al.
Publicado: (2023)

Membranous Nephropathy: Pilot Study of a Novel Regimen Combining Cyclosporine and Rituximab
por: Waldman, Meryl, et al.
Publicado: (2016)

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children
por: Bourcier, Tristan, et al.
Publicado: (2022)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population
por: Zhou, Tianbiao, et al.
Publicado: (2018)

Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
por: Zhang, Chengning, et al.
Publicado: (2020)

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis
por: Liu, Jiarong, et al.
Publicado: (2022)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
por: Wang, Hongyun, et al.
Publicado: (2023)

Cyclosporine A-Induced Conchal Hyperplasia with Nasal Obstruction in a Patient with Membranous Nephropathy
por: Tillmann, Frank-Peter, et al.
Publicado: (2022)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis
por: Lu, WanJun, et al.
Publicado: (2020)

Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
por: Cheong, Jamie, et al.
Publicado: (2018)

Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy
por: Kim, Yaeni, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hnkf8kavdra9hbpjv55rub4fg3